factually
Index/Topics/GLP-1 receptor agonists for diabetes and obesity

GLP-1 receptor agonists for diabetes and obesity

GLP-1 receptor agonists transformed diabetes and obesity treatment by delivering 15–20% weight loss in many trials

Fact-Checks

2 results
Jan 20, 2026

What does current clinical evidence say about gelatin or collagen for appetite control and weight management?

Current clinical evidence shows that gelatin and collagen (including collagen peptides) can modestly influence appetite-regulating hormones and short-term satiety in some studies, but results are inco...

Jan 14, 2026

Glp-1 substitutes

GLP-1 receptor agonists transformed diabetes and obesity treatment by delivering 15–20% weight loss in many trials, but true substitutes exist across several classes that offer more modest benefits or...